Detection of Potentially Inappropriate Medications in admitted patients in a tertiary hospital.

  • Esperanza Gonzalez Department of Clinical Pharmacology, Hospital Universitario de la Princesa, Teófilo Hernando Instituto, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria la Princesa, Madrid, Spain
  • Julio Marcotegui Department of Anesthesiology, Reanimation and Pain Treatment, Hospital Clínico San Carlos, Madrid, Spain.
  • Raquel Sampedro Department of Internal Medicine, Hospital Universitario de la Princesa, Madrid, Spain.
  • Sarahi Valdez-Acosta Department of Clinical Pharmacology, Hospital Universitario de la Princesa, Teófilo Hernando Instituto, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria la Princesa, Madrid, Spain
  • Francisco Abad-Santos Department of Clinical Pharmacology, Hospital Universitario de la Princesa, Teófilo Hernando Instituto, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria la Princesa, Madrid, Spain

Resumen

Background/Objectives: To determine the prevalence of potentially inappropriate medications (PIM) identified using the STOPP/START, Beers and PRISCUS criteria; and to determine the clinical variables related to the prescription of PIMs in older adults.

Design: Retrospective cross-sectional study.

Setting: Internal medicine/Geriatrics.

Participants: All patients over 65 years discharged from the Internal Medicine Service of La Princesa hospital during February 2014.

Measurements: Inappropriate prescriptions were detected with CheckTheMeds® computer tool.

Results The study included 143 participants, mean age 87±7 years. Using Beers criteria, 421 PIMs were identified in 114 patients, with STOPP criteria, 277 PIMs were identified in 111 patients, with START criteria 279 PIMs were identified in 113 patients and using PRISCUS 47 PIMs were identified in 42 patients. Correlation between STOPP and Beers was 70%.

Conclusions:  An association between PIM prescribing and polypharmacy was detected with different criteria. CheckTheMeds® is a useful tool to improve detection and management of PIM in order to obtain evidence-based pharmacological treatment.

Publicado
2020-07-09